Suchergebnisse - "Cantini, Fabrizio"

PubPharm (14)

1

Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4 : possible fallout on non-medical switching

enthalten in: Annals of the rheumatic diseases | 2020

von Cantini, F. | Benucci, M.

CommentOn: Ann Rheum Dis. 2019 Feb;78(2):192-200. - PMID 30396903

2

Non-medical switching : save today and pay tomorrow

enthalten in: Journal of medical economics | 2019

von Benucci, M. | Cantini, F.

CommentOn: J Med Econ. 2019 Nov;22(11):1162-1170. - PMID 31373527

3

Biosimilars for the treatment of psoriatic arthritis

enthalten in: Expert review of clinical immunology | 2019

von Cantini, F. | Benucci, M. | Li Gobbi, F. | +2

4

Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

enthalten in: Seminars in arthritis and rheumatism | 2017

von Cantini, F. | Niccoli, L. | Nannini, C. | +10

5

Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy : an Italian nationwide survey

enthalten in: International journal of rheumatic diseases | 2016

von Cantini, F. | Lubrano, E. | Marchesoni, A. | +5

6

Adalimumab, etanercept, infliximab, and the risk of tuberculosis : data from clinical trials, national registries, and postmarketing surveillance

enthalten in: The Journal of rheumatology. Supplement | 2014

von Cantini, F. | Niccoli, L. | Goletti, D.

7

High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy : data from GISEA, the Italian biologics register

enthalten in: Clinical rheumatology | 2014

von Iannone, F. | Gremese, E. | Gallo, G. | +18

8

Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis : an approach to a personalized medicine

enthalten in: Arthritis care & research | 2013

von Gremese, E. | Carletto, A. | Padovan, M. | +14

9

Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry : an appraisal of predictors

enthalten in: The Journal of rheumatology | 2012

von Iannone, F. | Gremese, E. | Atzeni, F. | +29

10

Etanercept in spondyloarthropathies. Part I : current evidence of efficacy

enthalten in: Clinical and experimental rheumatology | 2011

von Palazzi, C. | D'Angelo, S. | Cantini, F. | +7